David Llobet‐Navàs

Author

David Llobet‐Navàs

Hospital Universitari Arnau de Vilanova ORCID

Also Known As

D LLOBET, D Llobet, D Llobet-Navas, D. Llobet, D. Llobet-Navas, David Llobet, David Llobet-Navas, David Llobet-Navàs, David Llobet-Navás, David Llobet‐Navas

Publications

7.4K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitari Arnau de Vilanova Universitat de Lleida Instituto de Investigación Biomédica de Lleida Icahn School of Medicine at Mount Sinai Columbia University

About

David Llobet‐Navàs is an author at Hospital Universitari Arnau de Vilanova specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	2.2K
2	Engineering	2	2	198
3	Health Sciences	1	1	17
4	Natural Sciences	1	1	76
5	Biostatistics	1	1	94

David Llobet‐Navàs

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma Pavel Sumazin, Xuerui Yang, Hua‐Sheng Chiu, Cell Neuro-oncologyExtensive Microrna-mediated NetworkGliomaMicrorna DetectionSmall Rna	2011	704
A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia Daniel Herranz, Alberto Ambesi‐Impiombato, Teresa Palomero, Nature Medicine Hematological MalignancyT Cell DevelopmentLymphocyte DevelopmentImmune Cell DevelopmentNotch1-driven Myc Enhancer	2014	411
Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities Judit Pallarés, Elena Bussaglia, José‐Luis Martínez‐Guitarte, Modern Pathology MedicineCommercial AntibodiesGynecologyPathologyMolecular Pathology	2004	122
Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR<sup>−</sup>/HER2<sup>+</sup>breast cancers Ruth Rodríguez‐Barrueco, Jiyang Yu, Laura Saucedo-Cuevas, Genes & Development Autocrine Il-6–jak2–stat3–calprotectin AxisBreast OncologySignaling PathwayMedicineImmunology	2015	118
Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks Hua‐Sheng Chiu, David Llobet‐Navàs, Xuerui Yang, Genome Research	2014	110
Abnormalities in the NF‐κB family and related proteins in endometrial carcinoma Judit Pallarés, José‐Luis Martínez‐Guitarte, Xavier Dolcet, The Journal of Pathology	2004	106
Proteasome Inhibitors Induce Death but Activate NF-κB on Endometrial Carcinoma Cell Lines and Primary Culture Explants Xavier Dolcet, David Llobet‐Navàs, Mario Encinas, Journal of Biological Chemistry Proteasome InhibitorsChemoprevention StrategySerine 536ApoptosisPathology	2006	104
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer Núria Eritja, Bo‐Juen Chen, Ruth Rodríguez‐Barrueco, Autophagy MitophagyEngineeringKinase InhibitorsCancer BiologyTumor Biology	2017	104
Integration of Genomic Data Enables Selective Discovery of Breast Cancer Drivers Félix Sanchez-Garcia, Patricia Villagrasa, Junji Matsui, Cell Functional GenomicsEngineeringTranslational BioinformaticsBiomedical Data IntegrationMedicine	2014	94
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy Ruth Rodríguez‐Barrueco, Erin A. Nekritz, François Bertucci, Genes & Development Breast OncologyCancer BiologyMammary Gland DevelopmentTumor BiologyCancer Cell Biology	2017	90

Page 1